Given these findings, the variability in CD34+ cell levels could reflect a dynamic interplay between inflammatory responses, vascular repair mechanisms, and underlying systemic conditions, including age-related vascular remodeling or myocardial ischemia [44]. This evidence concerns the gene CD34 and myocardial ischemia.